Minnesota FOIA #N0102661M6

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)

On March 8, 2024, the Twin Cities government agency issued a purchase order to Yale University for $11,875.12 for the 'Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)'. The award was made to Yale University, located in New Haven, Connecticut, with vendor number 2141. The purchase involved a single lot of the specified therapy study, with Yale University as the recipient. The contract appears to be a one-time procurement for research services related to diabetes treatment. No specific contract duration or multi-year arrangement is indicated. The procurement was for a research project in the health sciences sector.

Description

Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)